Application 022013
- Type
- NDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OLUX E | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | 0.05% | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022013-001 | OLUX E | CLOBETASOL PROPIONATE | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022013-001 | OLUX E | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | RLD | 2007-01-12 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N022013-001 | OLUX E | 0.05% | AEROSOL, FOAM / TOPICAL | AB2 | RLD, RS | 2007-01-12 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022013-001 | AB2 | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N022013-001 | AB2 | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N022013-001 | AB2 | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N022013-001 | AB2 | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N022013-001 | AB2 | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N022013-001 | AB2 | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022013-001 | AB2 | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N022013-001 | AB2 | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N022013-001 | AB2 | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N022013-001 | AB2 | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N022013-001 | AB2 | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N022013-001 | AB2 | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N022013-001 | AB2 | 1 | ea99ee380514… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022013-001 | AB2 | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022013-001 | AB2 | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022013-001 | AB2 | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022013-001 | AB2 | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N022013-001 | AB2 | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N022013-001 | AB2 | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022013-001 | AB2 | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N022013-001 | AB2 | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N022013-001 | AB2 | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022013-001 | AB2 | 1 | cb3db0bc1861… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N022013-001 | 6730288 | 2019-09-08 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022013-001 | 7029659 | 2019-09-08 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022013-001 | 8460641 | 2028-11-05 | U-1410 | Drug product | 2013-07-02 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N022013-001 | 8962000 | 2025-08-31 | U-1410 | Drug product | 2015-03-26 | bb7c543d1eb4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Macleods Pharmaceuticals Limited | 5ad9c808-6095-4d86-b140-e0f6d4079a3a | 2022-12-23 | Adverse reactions | CLOBETASOL PROPIONATE |
| clobetasol propionate | CLOBETASOL PROPIONATE | Zydus Pharmaceuticals USA Inc. | 8618a3bc-5601-4273-a708-27b0ecd4c385 | 2022-10-06 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Zydus Pharmaceuticals USA Inc. | 98a25409-e84e-452b-8dc5-ad87842398e1 | 2022-10-05 | Adverse reactions | CLOBETASOL PROPIONATE |
| clobetasol propionate emollient formulation | CLOBETASOL PROPIONATE | Padagis Israel Pharmaceuticals Ltd | 5264dfb8-3f6f-4f20-958d-9b5855806dc8 | 2022-03-31 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Padagis Israel Pharmaceuticals Ltd | 3f75880b-9ead-4c6e-b999-3bd7e1643ce5 | 2022-03-31 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate (emollient) | CLOBETASOL PROPIONATE | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | fdfd83ee-dfb4-4c12-a74e-a0053e34e08c | 2021-07-01 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Northstar Rx LLC | 0d0e8e82-2b57-4cc0-a46b-bd08fb581deb | 2021-05-31 | Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Xiromed, LLC | 56e6d233-d9ee-f022-3be7-d100799a561e | 2020-11-06 | Adverse reactions | CLOBETASOL PROPIONATE |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Glenmark Pharmaceuticals Inc., USA | dfc58f73-e892-4fc3-8726-4e8d1546ebd3 | 2020-09-07 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Glenmark Pharmaceuticals Inc., USA | 420deed6-321f-4a2a-9042-1e61636621aa | 2020-08-26 | Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Actavis Pharma, Inc. | afd20e23-b7a6-46ca-bd8d-b7af9ff84201 | 2020-02-29 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| clobetasol propionate | CLOBETASOL PROPIONATE | Lupin Pharmaceuticals,Inc. | 3e0fe7b1-f511-491f-b74d-3ca00449835b | 2018-08-10 | Adverse reactions | CLOBETASOL PROPIONATE |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Glenmark Pharmaceuticals Inc., USA | e37dd885-889a-4bfd-9813-bb7b9b96cee1 | 2018-04-18 | Adverse reactions | CLOBETASOL PROPIONATE |
| clobetasol propionate | CLOBETASOL PROPIONATE | Novel Laboratories, Inc. | c7c03887-f84a-417e-a8f1-5272f530d0bb | 2016-05-21 | Adverse reactions | CLOBETASOL PROPIONATE |
| clobetasol propionate | CLOBETASOL PROPIONATE | Novel Laboratories, Inc. | afa1c879-36b9-401e-85d4-638ceec8f444 | 2016-04-28 | Adverse reactions | CLOBETASOL PROPIONATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-8055 | Clobetasol Propionate | Clobetasol Propionate | Mylan Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | Current |
| 0378-8055 | Clobetasol Propionate | Clobetasol Propionate | Mylan Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | Current |
| 0378-8147 | OLUX-E | clobetasol propionate | Mylan Pharmaceuticals Inc. | NDA | Current |
| 0378-8147 | OLUX-E | clobetasol propionate | Mylan Pharmaceuticals Inc. | NDA | Current |
| 0378-8147 | OLUX-E | clobetasol propionate | Mylan Pharmaceuticals Inc | NDA | Current |
| 40076-101 | OLUX-E | clobetasol propionate | Prestium Pharma, Inc. | NDA | Current |
| 40076-101 | OLUX-E | clobetasol propionate | Prestium Pharma, Inc. | NDA | Current |
| 40085-893 | Clobetasol Propionate Emulsion | clobetasol propionate | Renaissance Pharma, Inc. | NDA AUTHORIZED GENERIC | Current |
| 40085-893 | Clobetasol Propionate Emulsion | clobetasol propionate | Renaissance Pharma, Inc. | NDA AUTHORIZED GENERIC | Current |